Related Experiment Videos
Fludarabine phosphate in lymphoma: an important new therapeutic agent
P McLaughlin1, L E Robertson, M J Keating
1Department of Hematology, U.T.M.D. Anderson Cancer Center, Houston 77030, USA.
Cancer Treatment and Research
|January 1, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
New Agents and Strategies in CLL Treatment.
Leukemia & lymphoma·2016
Long-Term Results of CAP Therapy in Chronic Lymphocytic Leukemia.
Leukemia & lymphoma·2016
Clinical Trials and Translational Advances in Metabolic Targeting.
Cancer treatment and research·2026
Tools and Technologies for Studying Cancer Metabolism.
Cancer treatment and research·2026
Cancer and Immune Cells: A Metabolic Battle in the Tumor Microenvironment.
Cancer treatment and research·2026
Biomarkers of Cancer Metabolism and Therapeutic Response.
Cancer treatment and research·2026
Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches.
Cancer treatment and research·2026
Metabolic Reprogramming in Cancer Stem Cells.
Cancer treatment and research·2026
Evaluating Combined Sorafenib and Gemcitabine Treatment in HepG2 Cells and a NOD/SCID Mouse Xenograft Model: A Pilot Study.
Journal of visualized experiments : JoVE·2026
An Engineering-Editable Hybrid Membrane‑Camouflaged DNA Origami Drug Enables Checkpoint Blockade and Immune Activation for Triple-Negative Breast Cancer Immunotherapy.
Angewandte Chemie (International ed. in English)·2026
Chemotherapy-Activated GSK3β-DNMT1 Signaling Upregulates CD47 to Evade Macrophage Phagocytosis and Drive Temozolomide Resistance in Glioblastoma.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Restoration of m6A-Modified circPSMB1 Suppresses Chordoma Progression and Enables Local Nanotherapeutic Intervention.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026